Abstract:Duchenne muscular dystrophy (DMD), inherited in an X-linked recessive manner, is a lethal disease affecting about 1/3600 males at birth. Mutations in the DMD gene have been shown to be the key determinant of the occurrence of DMD disease. Nowadays, removal of DMD exon 51 has been used as a common therapeutic intervention in disease animal models. Despite all these efforts, the clinical significance of DMD exon 51 has hardly been explored in large animals. Our study aimed to investigate the role of DMD exon 51 in the pathogenesis of DMD disease. We generated cell clones and miniature pigs lacking DMD exon 51 by CRISPR-Cas9 system. Significant changes in cell membrane integrity and apoptosis were found in genetically modified cell clones. All DMD pigs showed the accelerated pathological process of Duchenne muscular dystrophy. In addition, the ability of the small intestine of DMD pigs to digest and absorb nutrients was significantly reduced, compared to wild-type littermates. To conclude, this research could assist in our understanding of the pathological process of Duchenne muscular dystrophy. The findings of our investigation complemented those of earlier studies and might provide new insights into slow down the progression of this disease. Funding: This work was supported by grants from National Natural Science Foundation of China (No. 31572345 and 31472053), the Program for JLU Science and Technology Innovative Research Team (2017TD-28), the Fundamental Research Funds for the Central Universities, the Humanized IAPP gene preparation of human diabetes miniature swine model. Jilin Province Science and Technology Development Plan Project (No.20170623035TC) and the Program for Changjiang Scholars and Innovative Research Team in University in China (No. IRT16R32). Declaration of Interest: The authors declare no competing interest. Ethical Approval: All animal studies were approved by the Animal Welfare and Research Ethics Committee at Jilin University, and all procedures were conducted strictly in accordance with the Guide for the Care and Use of Laboratory Animals. All surgeries were performed under anesthesia, and every effort was made to minimize animal suffering.

Pig models for translational Duchenne muscular dystrophy research

Research Progress on Disease Models and Gene Therapy of Duchenne Muscular Dystrophy

Severe cardiac and skeletal manifestations in DMD-edited microminipigs: an advanced surrogate for Duchenne muscular dystrophy

Miniature Pigs Carrying DMD Exon51 Deletion Suffered from Severe Myocardial Damage, Accelerated Muscle Atrophy and Malabsorption

Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy

Behavioral, Biochemical and Pathological Characterization of a New MDX Mouse Model of Duchenne Muscular Dystrophy

A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing

Pathological alterations in the gastrointestinal tract of a porcine model of DMD

Respiratory Characterization of a Humanized Duchenne Muscular Dystrophy Mouse Model

A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9

The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy

The use of genetically humanized animal models for personalized medicine approaches

Phenotypic features of dystrophin gene knockout pigs harboring a human artificial chromosome containing the entire dystrophin gene

Generation and characterisation of mouse models of Duchenne Muscular Dystrophy (DMD)

The BALB/c. mdx 62 mouse exhibits a dystrophic muscle pathology and is a novel model of Duchenne muscular dystrophy

Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models

Advances in Pig Models of Human Diseases

Correction of Three Prominent Mutations in Mouse and Human Models of Duchenne Muscular Dystrophy by Single-Cut Genome Editing

Humanizing the mdx mouse model of DMD: the long and the short of it

Profound cellular defects attribute to muscular pathogenesis in the rhesus monkey model of Duchenne muscular dystrophy

Evaluating Genetic Modifiers of Duchenne Muscular Dystrophy Disease Progression Using Modeling and MRI